BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23951092)

  • 1. Inhibition of PPARα induces cell cycle arrest and apoptosis, and synergizes with glycolysis inhibition in kidney cancer cells.
    Abu Aboud O; Wettersten HI; Weiss RH
    PLoS One; 2013; 8(8):e71115. PubMed ID: 23951092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARα inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growth.
    Abu Aboud O; Donohoe D; Bultman S; Fitch M; Riiff T; Hellerstein M; Weiss RH
    Am J Physiol Cell Physiol; 2015 Jun; 308(11):C890-8. PubMed ID: 25810260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms.
    Yamasaki D; Kawabe N; Nakamura H; Tachibana K; Ishimoto K; Tanaka T; Aburatani H; Sakai J; Hamakubo T; Kodama T; Doi T
    Eur J Cell Biol; 2011 Aug; 90(8):657-64. PubMed ID: 21514001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Holliday junction‑recognition protein modulates apoptosis, cell cycle arrest and reactive oxygen species stress in human renal cell carcinoma.
    Yuan JS; Chen ZS; Wang K; Zhang ZL
    Oncol Rep; 2020 Sep; 44(3):1246-1254. PubMed ID: 32582972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing glucose-regulated protein 78 induced renal cell carcinoma cell line G1 cell-cycle arrest and resistance to conventional chemotherapy.
    Lin JA; Fang SU; Su CL; Hsiao CJ; Chang CC; Lin YF; Cheng CW
    Urol Oncol; 2014 Jan; 32(1):29.e1-11. PubMed ID: 23428538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of PPARα inhibition in head and neck paraganglioma cells.
    Florio R; De Lellis L; di Giacomo V; Di Marcantonio MC; Cristiano L; Basile M; Verginelli F; Verzilli D; Ammazzalorso A; Prasad SC; Cataldi A; Sanna M; Cimini A; Mariani-Costantini R; Mincione G; Cama A
    PLoS One; 2017; 12(6):e0178995. PubMed ID: 28594934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidation.
    Kamarajugadda S; Becker JR; Hanse EA; Mashek DG; Mashek MT; Hendrickson AM; Mullany LK; Albrecht JH
    Oncotarget; 2016 Jul; 7(30):47674-47686. PubMed ID: 27351284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ara-c induces cell cycle G1/S arrest by inducing upregulation of the INK4 family gene or directly inhibiting the formation of the cell cycle-dependent complex CDK4/cyclin D1.
    Sun F; Li N; Tong X; Zeng J; He S; Gai T; Bai Y; Liu L; Lu K; Shen J; Han M; Lu C; Dai F
    Cell Cycle; 2019 Sep; 18(18):2293-2306. PubMed ID: 31322047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF
    Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-proliferative potential of Glucosamine in renal cancer cells via inducing cell cycle arrest at G0/G1 phase.
    Wang LS; Chen SJ; Zhang JF; Liu MN; Zheng JH; Yao XD
    BMC Urol; 2017 May; 17(1):38. PubMed ID: 28558682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of the nuclear exporter exportin-1 attenuates kidney cancer growth.
    Wettersten HI; Landesman Y; Friedlander S; Shacham S; Kauffman M; Weiss RH
    PLoS One; 2014; 9(12):e113867. PubMed ID: 25461627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of arachidonic acid and peroxisome proliferator-activated receptor-alpha in breast cancer tissues are associated with promoting cancer cell proliferation.
    Chang NW; Wu CT; Chen DR; Yeh CY; Lin C
    J Nutr Biochem; 2013 Jan; 24(1):274-81. PubMed ID: 22902323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dauricine inhibits viability and induces cell cycle arrest and apoptosis via inhibiting the PI3K/Akt signaling pathway in renal cell carcinoma cells.
    Zhang S; Ren Y; Qiu J
    Mol Med Rep; 2018 May; 17(5):7403-7408. PubMed ID: 29568902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telmisartan-Induced Cytotoxicity via G
    Tsujiya Y; Hasegawa A; Yamamori M; Okamura N
    Biol Pharm Bull; 2021; 44(12):1878-1885. PubMed ID: 34853271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin induces G0/G1 arrest and apoptosis in hormone independent prostate cancer DU-145 cells by down regulating Notch signaling.
    Sha J; Li J; Wang W; Pan L; Cheng J; Li L; Zhao H; Lin W
    Biomed Pharmacother; 2016 Dec; 84():177-184. PubMed ID: 27657825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway.
    Wang G; Cao R; Wang Y; Qian G; Dan HC; Jiang W; Ju L; Wu M; Xiao Y; Wang X
    Sci Rep; 2016 Oct; 6():35783. PubMed ID: 27779188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.
    Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y
    Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sunitinib induces cellular senescence via p53/Dec1 activation in renal cell carcinoma cells.
    Zhu Y; Xu L; Zhang J; Hu X; Liu Y; Yin H; Lv T; Zhang H; Liu L; An H; Liu H; Xu J; Lin Z
    Cancer Sci; 2013 Aug; 104(8):1052-61. PubMed ID: 23578198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-206 functions as a novel cell cycle regulator and tumor suppressor in clear-cell renal cell carcinoma.
    Xiao H; Xiao W; Cao J; Li H; Guan W; Guo X; Chen K; Zheng T; Ye Z; Wang J; Xu H
    Cancer Lett; 2016 Apr; 374(1):107-116. PubMed ID: 26808577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting glycolysis with 2-deoxy-D-glucose sensitizes primary cell cultures of renal cell carcinoma to tyrosine kinase inhibitors.
    Simon AG; Esser LK; Ellinger J; Branchi V; Tolkach Y; Müller S; Ritter M; Kristiansen G; Muders MH; Mayr T; Toma MI
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2255-2265. PubMed ID: 32533404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.